Ray Dalio's XRAY Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 476,608 shares of DENTSPLY SIRONA Inc. (XRAY) worth $5.45 M, representing 0.02% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in XRAY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 360,295 shares. Largest reduction occurred in Q1 2025, reducing 225,523 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's DENTSPLY SIRONA (XRAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly DENTSPLY SIRONA (XRAY) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +26,186 | Add 5.81% | 476,608 | $11.43 |
| Q3 2025 | +360,295 | Add 399.76% | 450,422 | $12.69 |
| Q2 2025 | +90,127 | New Buy | 90,127 | $15.88 |
| Q1 2025 | -225,523 | Sold Out | 0 | $0.00 |
| Q4 2024 | +44,171 | Add 24.36% | 225,523 | $18.98 |
| Q3 2024 | -120,669 | Reduce 39.95% | 181,352 | $27.06 |
| Q2 2024 | +38,082 | Add 14.43% | 302,021 | $24.91 |
| Q1 2024 | -62,549 | Reduce 19.16% | 263,939 | $33.19 |
| Q4 2023 | -39,950 | Reduce 10.90% | 326,488 | $35.59 |
| Q3 2023 | +24,796 | Add 7.26% | 366,438 | $34.16 |
| Q2 2023 | +53,775 | Add 18.68% | 341,642 | $40.02 |
| Q1 2023 | -51,448 | Reduce 15.16% | 287,867 | $39.28 |
| Q4 2022 | -132,107 | Reduce 28.02% | 339,315 | $31.84 |
| Q3 2022 | +34,719 | Add 7.95% | 471,422 | $28.35 |
| Q2 2022 | +10,446 | Add 2.45% | 436,703 | $35.73 |
| Q1 2022 | +143,597 | Add 50.80% | 426,257 | $49.22 |
| Q4 2021 | +43,784 | Add 18.33% | 282,660 | $55.79 |
| Q3 2021 | +3,105 | Add 1.32% | 238,876 | $58.05 |
| Q2 2021 | +98,913 | Add 72.27% | 235,771 | $63.26 |
| Q1 2021 | +26,220 | Add 23.70% | 136,858 | $63.81 |
| Q4 2020 | +55,770 | Add 101.64% | 110,638 | $52.36 |
| Q3 2020 | +54,868 | New Buy | 54,868 | $43.72 |
| Q2 2020 | -7,348 | Sold Out | 0 | $0.00 |
| Q1 2020 | +7,348 | New Buy | 7,348 | $38.79 |
| Q1 2019 | -24,774 | Sold Out | 0 | $0.00 |
| Q4 2018 | +2,789 | Add 12.69% | 24,774 | $37.22 |
| Q3 2018 | +21,985 | New Buy | 21,985 | $37.75 |
| Q2 2018 | -75,346 | Sold Out | 0 | $0.00 |
| Q1 2018 | +75,346 | New Buy | 75,346 | $50.31 |
| Q4 2016 | -4,500 | Sold Out | 0 | $0.00 |
| Q3 2016 | -1,500 | Reduce 25.00% | 4,500 | $59.33 |
| Q2 2016 | +6,000 | New Buy | 6,000 | $62.00 |
Ray Dalio's DENTSPLY SIRONA Investment FAQs
Ray Dalio first purchased DENTSPLY SIRONA Inc. (XRAY) in Q2 2016, acquiring 6,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held DENTSPLY SIRONA Inc. (XRAY) for 32 quarters since Q2 2016.
Ray Dalio's largest addition to DENTSPLY SIRONA Inc. (XRAY) was in Q3 2025, adding 450,422 shares worth $5.72 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 476,608 shares of DENTSPLY SIRONA Inc. (XRAY), valued at approximately $5.45 M.
As of the Q4 2025 filing, DENTSPLY SIRONA Inc. (XRAY) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in DENTSPLY SIRONA Inc. (XRAY) was 476,608 shares, as reported at the end of Q4 2025.